How Acia Is Cashing In Huge
Shares of Acacia Communications have pulled back on news of a secondary offering of more than 4 million shares.
All Work
Chris Lange
Everspin Sets Expected Price for IPO
Everspin Technologies expects to price its 5 million shares at $8 apiece for an initial public offering is valued up to $46 million.
Why CIT Group Is Flying High on Friday
Shares of CIT Group saw a handy gain early on Friday after the company announced that it will be selling its commercial aircraft leasing business.
Why Inventory Global Shares Are Sliding
Inventory Global, Inc. (NASDAQ: INVT) saw its shares slide on Thursday after the company announced that it would be having a secondary offering. The company intends to price 6 million shares at $1 per…
Zumiez Soars on September Sales and Guidance
Zumiez, Inc. (NASDAQ: ZUMZ) shares are making a run on Thursday after the company reported its sales results for September 2016. At the same time, the company also upped the stakes when it increased…
Idera Pharmaceuticals Sinks on Secondary Offering
Shares of Idera Pharmaceuticals sank on Thursday after the company announced that it intends to have a secondary offering.
GDS Files for IPO
GDS Holdings has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Alnylam Pharma Crashes on Discontinued Late-Stage Trial
Alnylam Pharmaceuticals saw its shares crash on Thursday after the company announced that it will be discontinuing one of its late-stage trials.
Coupa Software More Than Doubles in IPO
Coupa Software entered the market sharply higher than anyone had really expected.
Advanced Disposal Services IPO Brings Mixed Reaction
The reaction was somewhat mixed when Advanced Disposal Services entered the market on Thursday.
Aurinia Pharma Skyrockets on Positive Data From Lupus Study
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) has been on a meteoric rise over the past month. In this time the stock has gained over 150%, on what has been relatively little news for such a…
Why Scynexis Is Making a Run
Scynexis shares made a handy gain early on Thursday after the company announced the results from a couple of its mid-stage trials.
7 Key FDA Decisions and Clinical Trial Results Coming in Q4
24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in November and December.
Yum! Brands Disappoints on Earnings Ahead of China Split
Yum! Brands Inc. (NYSE: YUM) reported third-quarter financial results after the markets closed on Wednesday. The company posted $1.09 in earnings per share (EPS) on $3.32 billion in revenue. There were consensus estimates from…
SEC Settles Misrepresentation Case With Credit Suisse and Executive
The U. S. Securities and Exchange Commission (SEC) recently announced that Credit Suisse Group A.G. (NYSE: CS) has agreed to pay a $90 million penalty and admit wrongdoing to settle charges that it misrepresented…
Immunomedics Falls Sharply on Secondary Offering
Shares of Immunomedics dropped sharply on Wednesday after the company announced the pricing of its secondary offering.
How Analysts View Micron After Earnings
While this earnings report more or less solidified Micron’s position at its current price level, some analysts are still seeing a little more room to run, though one standout that believes this company is…
Eli Lilly Expands Pet Vaccines Portfolio With Boehringer Acquisition
Eli Lilly shares had a bit of a boost on Wednesday after it was announced that one of its subsidiaries would be acquiring Boehringer Ingelheim Vetmedica.
Monsanto Posts Mixed Q4 Results Ahead of Bayer Merger
Monsanto reported mixed fiscal fourth-quarter financial results before the markets opened on Wednesday.
Constellation Brands Wows With Q2 Earnings
Constellation Brands reported better-than-expected fiscal second-quarter financial results before the markets opened on Wednesday.